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EFFECT OF RANITIDINE AND CIMETIDINE TWICE DAILY ON THE 24 H INTRAGASTRIC ACIDITY IN MAN
Ranitidine is a new specific histamine H2-receptor antagonist. Its inhibitory action lasts up to 12 h, so that ranitidine can be prescribed twice daily. Some workers report that cimetidine likewise can be used twice daily in the treatment of peptic ulcer disease (Eckardt, 1981; Kerr, 1981) .
The aim of the present study was, therefore, to compare the effect of twice daily administration of ranitidine, cimetidine and placebo on the 24 h intragastric acidity in man.
Eight healthy subjects (five male, three female) with a mean age of 25 years participated in this study. Each subject underwent the test on three different occasions, receiving in a double-blind cross-over randomized fashion ranitidine (150 mg twice daily), cimetidine (400 mg twice daily) and placebo at 08.00 h and 20.00 h. A nasogastric tube was positioned 1 h before the beginning of the test. The menu (breakfast at 08.00 h, mid-morning drink at 10.30 h, lunch at 13.00 h, coffee-break at 15.30 h, dinner at 19.00 h and night-cap at 22.30 h) was identical during the three studies.
Starting at 08.00 h in the morning, a 5-10 ml sample of gastric contents was aspirated at 1 hourly intervals using syringe suction according to Walt et al. (1981) . Gastric juice was titrated with 0.1 N NaOH to pH 7.0.
The results were expressed in terms of mean hourly H+-concentration (mmol: 1). Statistical analysis was made using the Wilcoxon-text for paired samples.
The effects of the different regimens on 24 h gastric acidity are illustrated in Figure 1 .
Compared with placebo, gastric HI-concentration between 08.00 h and 19.00 h was diminished by cimetidine from 17.15 + 4.61 (+ s.e. mean) mmol, 1 to 10.43 + 1.92 mmol l (P < 0.01, 39%-inhibition) and by ranitidine to 4.79 + 1.10 mmol,l (P < 0.01 vs placebo and cimetidine, 72% inhibition).
Nocturnal H+-activity (20.00 h to 07.00 h) was decreased by cimetidine 400 mg twice daily from 28.69 + 6.44 mmol I to 16.12 + 2.73 mmol I (P < 0.01, 44% inhibition) and by ranitidine 150 mg twice daily to 7.96 + 1.86 mmolil (P < 0.01 vs placebo and cimetidine, 72% inhibition).
Whilst ranitidine induced a sustained inhibition lasting the whole 24 h period, cimetidine has proved to be less effective late in the afternoon and early in the morning.
The pattern of 24 h gastric acidity observed in these studies revealed that both H2-receptor antagonists in the twice daily regimen caused a significant reduction in hydrogen ion activity throughout the period. The suppressing effect of ranitidine was significantly more pronounced than that due to cimetidine.
Although there is none too close a relationship between gastric acid secretion and the extent of therapeutic response, reduction of gastric acidity, as achieved with cimetidine 400 mg twice daily in this study, might prove insufficient in some ulcer patients with elevated acid output. 
